Fighting deadly leukemia by developing a new targeted therapy & diagnostic

Chemotherapy, the standard cancer treatment, is largely prescribed by informed guesses. Because this inaccurate method kills both cancerous and healthy cells, patients suffer from nasty side effects and don’t usually get a drug that works for them the first time, if they get one that works at all.

We’re developing a targeted therapy for a highly lethal leukemia and a diagnostic to determine which patients will respond well to the drug.

We’re ready to start Phase 1b/2 of clinical trials with leading hematology oncology experts.

For more info: http://